Keeping her grandfather’s cancer a secret from him felt counterintuitive to Tina Chai as a teen, but conversations with other Chinese Americans helped her understand the reasons Chinese physicians and families may practice cancer nondisclosure. Read More…
Amid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine. Most health care providers are familiar with triage, the careful and intentional orchestration of patient care to ensure that Read more…
Women who receive radiotherapy for rectal cancer may be at an increased risk of uterine and ovarian cancer, a new study suggests. In an analysis of information from the SEER database on more than 20,000 female patients diagnosed with rectal Read more…
The FDA has approved the use of osimertinib as a treatment for patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). According to a release from the manufacturer, the approval is for patients who have had Read more…
Antitumor activity was observed in the study population. Dose modifications of cabozantinib improve long-term tolerability. Biomarkers are needed to identify patient populations most likely to benefit. Further study of cabozantinib with or without panitumumab in patients with metastatic colorectal cancer Read more…
Treatment for patients with metastatic colorectal cancer (mCRC) typically involves multiple lines of therapy with eventual development of treatment resistance. In this single arm, phase II study involving heavily pre-treated patients, the combination of sorafenib and capecitabine (SorCape) yielded a Read more…
Circulating tumor cell count is a reliable biomarker for choosing between chemotherapy or endocrine therapy for patients with HER2-negative metastatic breast cancer, according to a recent study published in JAMA Oncology (2020 Nov 5. doi:10.1001/jamaoncol.2020.5660). “The choice between chemotherapy and endocrine therapy Read more…
Small Cell Lung Cancer Diagnosis Kristie L. Kahl: To start, can you discuss what the difference is between a small cell and a non-small cell lung cancer diagnosis? Wade T. Iams, MD: Those are the 2 major types of lung cancer, and Read more…
WASHINGTON — The FDA approved the combination of nivolumab (Opdivo) plus cabozantinib (Cabometyx) on Friday for treating advanced renal cell carcinoma (RCC) in the first-line setting. Support for approval came from CheckMate-9ER, a phase III trial that randomized 651 previously untreated patients with Read more…
The National Comprehensive Cancer Network (NCCN) today released guidance for COVID-19 vaccinations in patients with cancer. The NCCN created a committee of hematology and oncology experts who specialized in infectious disease, vaccine development and delivers, medical ethics, and health information Read more…